GLABF (Gemina Laboratories) Total Equity: $-3.68 Mil (As of Oct. 2025)


What is Gemina Laboratories Total Equity?

Gemina Laboratories GLABF -27.59% Total Equity is $-3.68 Mil as of Oct. 2025. The stock has 2 warning signs investors should review.

Gemina Laboratories's total equity for the quarter that ended in Oct. 2025 was $-3.68 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Gemina Laboratories Total Equity Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Total Equity Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Total Equity
0.13 0.75 -0.05 -1.18 -3.08

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.52 -3.08 -3.14 -3.51 -3.68

Gemina Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Gemina Laboratories's Total Equity for the fiscal year that ended in Jan. 2025 is calculated as

Total Equity=Total Assets(Q: Jan. 2025 )-Total Liabilities(Q: Jan. 2025 )
=0.999-4.082
=-3.08

Gemina Laboratories's Total Equity for the quarter that ended in Oct. 2025 is calculated as

Total Equity=Total Assets(Q: Oct. 2025 )-Total Liabilities(Q: Oct. 2025 )
=0.794-4.47
=-3.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-3.68 Mil mean?
Gemina Laboratories (GLABF) has a Total Equity of $-3.68 Mil as of Oct. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Gemina Laboratories and its competitors.
Is Gemina Laboratories' Total Equity too high?
Gemina Laboratories' current Total Equity is $-3.68 Mil.
How does Gemina Laboratories' Total Equity compare to VRTX and REGN?
Gemina Laboratories' Total Equity of $-3.68 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Gemina Laboratories and its competitors. Gemina Laboratories's current Total Equity is $-3.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Total Equity of $-3.68 Mil. The current Total Equity is $-3.68 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Total Equity is $-3.68 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.